Skip to main content

Advertisement

Log in

ASO Visual Abstract: Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroyuki Daiko MD, PhD, FACS.

Ethics declarations

Disclosures

Ken Kato reports consulting fees from Bristol Myers Squibb, Merck Sharp & Dohme, BeiGene, Roche, AstraZeneca, and Bayer; honoraria from Ono Pharmaceuticals, Bristol Myers Squibb, and Taiho; research funding from Ono Pharmaceuticals, Bristol Myers Squibb, Merck Sharp & Dohme, BeiGene, Chugai, Shionogi, AstraZeneca, and Bayer for research subjects outside the submitted work. Shota Igaue, Ryoko Nozaki, Daichi Utsunomiya, Yuto Kubo, Kentaro Kubo, Daisuke Kurita, Shun Yamamoto, Koshiro Ishiyama, Junya Oguma, and Hiroyuki Daiko have no conflicts of interest to declare in relation to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Igaue, S., Nozaki, R., Utsunomiya, D. et al. ASO Visual Abstract: Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment. Ann Surg Oncol 31, 1589–1590 (2024). https://doi.org/10.1245/s10434-023-14754-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14754-z

Navigation